Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

The Smartphone as Diagnostic Tool

Larry Beresford  |  March 19, 2018

SAN DIEGO—Increasingly, technological advances are placing new tools into the hands of office-based rheumatologists. And they don’t have to cost a lot in capital equipment outlays by the medical group, because some of the best advances can be accessed via the device that is already in most doctors’ pockets, their smartphone. Smartphone technology gets more…

Filed under:Meeting ReportsTechnology Tagged with:ACR/ARHP Annual Meetingsmartphone

Updates on Giant Cell Arteritis

Susan Bernstein  |  March 19, 2018

SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

Filed under:Meeting ReportsVasculitis Tagged with:ACR/ARHP Annual Meetinggiant cell arteritis (GCA)

Updates on Managing Lupus Complications

Susan Bernstein  |  March 17, 2018

SAN DIEGO—To manage patients with systemic lupus erythematous (SLE), rheuma­tologists must be aware of potentially serious complications affecting many organ systems. On Nov. 7 at the 2017 ACR/ARHP Annual Meeting, two experts offered insights on cardiovascular and hematological complications of lupus. Myocardial Disease in Lupus Lupus patients are at increased risk for heart-related complications, especially…

Filed under:Meeting ReportsSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetinganemiaCoombshemolysisLupusmyocardial inflammationSLEsplenectomy

The Battle with Insurance Companies to Obtain Prescriptions

Philip Seo, MD, MHS  |  March 17, 2018

If you are a news junkie, then you know that a tick-tock is a story that relies heavily on chronology, counting down the events of the day, in order, as inexorably as the ticking clock. These types of timeline stories have become very popular in the fast-paced world of modern politics, in which readers eat…

Filed under:Legal UpdatesLegislation & AdvocacyOpinionRheuminationsSpeak Out Rheum Tagged with:drug benefitspharmacy benefit managersprescription

Case Report: Metoprolol-Induced Arthralgia

Case Report: Metoprolol-Induced Arthralgia

Saba Ziaee, MD, & Zineb Aouhab, MD  |  March 17, 2018

Various drugs are known to cause musculoskeletal symptoms, such as arthralgias, myalgias, drug-induced lupus and serum sickness.1 In the rheumatology world, the most commonly recognized drugs that can cause musculoskeletal symptoms are hydralazine, minocycline, fluoroquinolones and, recently, the dipeptidyl peptidase 4 (DPP-4) inhibitor class of medications. Although beta blockers also have a noted side effect…

Filed under:ConditionsSoft Tissue Pain Tagged with:arthralgiasbeta blockersmetoprolol

FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval

Michele B. Kaufman, PharmD, BCGP  |  March 7, 2018

After reviewing a 10-year study, the FDA cautions that prescribing clarithromycin to patients with heart disease increases the risk of heart problems or death…

Filed under:Drug Updates Tagged with:acute painantibioticsApadazclarithromycinHeart Disease

Inflammation in OA: Signs & Treatment Opportunities

Carina Stanton  |  March 6, 2018

The demonstrated connection between persistent effusion-synovitis and cartilage damage in certain osteoarthritis (OA) patients has implications for targeted treatment that updates previous OA treatment parameters…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:cartilagecartilage lossinflammationOsteoarthritissynovitissynovitis effusion

Advocacy Team Celebrates Healthcare Fixes, Prepares to Face New Threats

Angus Worthing, MD, FACP, FACR  |  March 1, 2018

Greetings, Advocates! Great news for the rheumatology community came on Feb. 9, when the Bipartisan Budget Act of 2018 was enacted. It contains several critical healthcare fixes pertinent to rheumatology. First, after hundreds of emails, meetings, letters to the editor, an op-ed, and a forceful 109-member coalition (led by the ACR and including many state…

Filed under:Legislation & Advocacy Tagged with:ACR advocacyACR Government Affairs CommitteeAngus WorthingBipartisan Budget ActD.C. updateGAChealthcare fixeshigh drug costsPart B drug costs

Secukinumab Promising for Sustained Improvements in Palmoplantar & Nail Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  February 28, 2018

In clinical trials, secukinumab proved safe and effective as a long-term treatment for both palmoplantar and nail psoriasis…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:nail psoriasisnailspalmoplantar psoriasisPsoriasissecukinumab

Is Patient-Centered Care Effective for Rheumatology?

Karen Appold  |  February 21, 2018

Patient-centered care requires increased communication and a proactive patient. But how does it benefit a rheumatology practice? According to Stanford Shoor, MD, patient-centered care offers a team-based approach that can improve satisfaction in care and positively affect RA-specific outcomes…

Filed under:Practice Support Tagged with:patient carepatient centerednesspatient communicationpatient satisfactionpatient-centered carephysician-patient communication

  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 162
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences